0001096906-24-000650.txt : 20240328 0001096906-24-000650.hdr.sgml : 20240328 20240328140615 ACCESSION NUMBER: 0001096906-24-000650 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240321 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mycotopia Therapies, Inc. CENTRAL INDEX KEY: 0001763329 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870645794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56022 FILM NUMBER: 24797564 BUSINESS ADDRESS: STREET 1: 480 22ND STREET CITY: HEYBURN STATE: ID ZIP: 83336 BUSINESS PHONE: 208-677-2020 MAIL ADDRESS: STREET 1: 480 22ND STREET CITY: HEYBURN STATE: ID ZIP: 83336 FORMER COMPANY: FORMER CONFORMED NAME: 20/20 Global, Inc. DATE OF NAME CHANGE: 20190102 8-K 1 tpia-20240321.htm MYCOTOPIA THERAPIES, INC. - FORM 8-K SEC FILING MYCOTOPIA THERAPIES, INC. - Form 8-K SEC filing
0001763329 false 0001763329 2024-03-21 2024-03-21

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 21, 2024

 

MYCOTOPIA THERAPIES, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-56022

 

87-0645794

(State of Incorporation)

 

(Commission File Number)

 

(IRS Employer ID No.)

 

100 SE 2nd St, Suite 2000

Miami, Florida 33131

(Address of Principal Executive Offices)

 

(954) 233-3511

(Registrant's Telephone Number including Area Code)

 

 

(Former name or address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 4.01 Changes in Registrant’s Certifying Accountant.

 

On March 21, 2024, Mycotopia Therapies, Inc. (the “Company”) was notified by its independent registered public accounting firm, Pinnacle Accountancy Group of Utah (“Pinnacle”) that they were resigning. During the fiscal year ended December 31, 2022, and the quarterly periods through September 30, 2023, there were no (i) disagreements between the Company and Pinnacle on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, any of which, if not resolved to Pinnacle’s satisfaction, would have caused Pinnacle to make reference thereto in its audit report on the financial statements of the Company for such period, or (ii) reportable events” within the meaning of Item 304(a)(1)(v) of Regulation S-K. There were no disputes or disagreements between the Company and Pinnacle during the time it was the Company’s independent registered public accounting firm through the date of resignation.

 

The Company provided Pinnacle with a copy of this disclosure before its filing with the SEC. The Company requested that Heaton provide us with a letter addressed to the SEC stating whether or not it agrees with the above statements. That letter is attached hereto as Exhibit 16.1.

 

New Independent Registered Public Accounting Firm

 

The Company’s Board of Directors appointed Fruci & Associates II, PLLC (“Fruci”) as its new independent registered public accounting firm, effective as of March 21, 2024. During the two most recent fiscal years and through the date of the Company’s engagement of Fruci, the Company did not consult with Fruci regarding either (1) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, or (2) any matter that was either the subject of a disagreement (as defined in Regulation S-K Item 304(a)(1)(v)), during the two most recent fiscal years.

 

Prior to engaging Fruci, Fruci did not provide the Company with either written or oral advice that was an important factor considered by the Company in reaching a decision to engage Heaton as its independent accounting firm.

 

 

 

 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

 

Exhibit No.

 

Description

16.1

 

Letter from Pinnacle Accountancy Group of Utah

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Mycotopia Therapies, Inc.

 

 

a Nevada corporation

 

 

 

Date: March 27, 2024

 

By:     /s/Ben Kaplan                                                                      

 

 

Name: Ben Kaplan

 

 

Title:   Chief Executive Officer and Principal Accounting Officer

 EX-16.1 2 tpia_ex16z1.htm LETTER FROM PINNACLE ACCOUNTANCY GROUP OF UTAH

Exhibit 16.1

 

March 27, 2024

 

Securities and Exchange Commission (the “Commission”)

 

100 F Street, NE

Washington, DC 20549

 

Dear Ladies and Gentleman:

 

We are the former independent registered public accounting firm for Mycotopia Therapies, Inc. (the “Company”). We have read the statements made by the Company, which were provided to us and which we understand will be filed with the Commission pursuant to Item 4.01 Changes in Registrant’s Certifying Accountant of its current report on Form 8-K (the “Current Report”) and are in agreement with the disclosure in the Current Report, insofar as it pertains to our firm.

 

We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.

 

Sincerely,

 

/s/ Pinnacle Accountancy Group of Utah

 

PINNACLE ACCOUNTANCY GROUP OF UTAH

(dba of Heaton & Company, PLLC)

Farmington, UT

 

 EX-101.DEF 3 tpia-20240321_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 tpia-20240321_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Written Communications Entity Address, Address Line Two Soliciting Material Number of common stock shares outstanding Well-known Seasoned Issuer SEC Form Registrant CIK Fiscal Year End Entity Address, Address Line One Tax Identification Number (TIN) Trading Exchange Local Phone Number Entity File Number Amendment Description Shell Company Period End date Details Small Business Entity Address, Postal Zip Code Entity Address, City or Town Amendment Flag Interactive Data Current Voluntary filer Trading Symbol City Area Code Entity Incorporation, State or Country Code Filer Category Registrant Name Ex Transition Period Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Entity Address, State or Province Public Float Emerging Growth Company Current with reporting EX-101.PRE 5 tpia-20240321_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 6 tpia-20240321.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information
Mar. 21, 2024
Details  
Registrant CIK 0001763329
Registrant Name MYCOTOPIA THERAPIES, INC.
SEC Form 8-K
Period End date Mar. 21, 2024
Tax Identification Number (TIN) 87-0645794
Emerging Growth Company false
Entity Incorporation, State or Country Code NV
Entity File Number 000-56022
Entity Address, Address Line One 100 SE 2nd St
Entity Address, Address Line Two Suite 2000
Entity Address, City or Town Miami
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33131
City Area Code 954
Local Phone Number 233-3511
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,9P?%@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #&<'Q82<@[TNX K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)VUE*:&;B^))07!!\1:2V=U@TX9DI-VW-XV[740?P&-F_GSS M#4RGO=!CP.

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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 20 1 false 0 0 false 0 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports tpia-20240321.htm tpia-20240321.xsd tpia-20240321_def.xml tpia-20240321_lab.xml tpia-20240321_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tpia-20240321.htm": { "nsprefix": "fil", "nsuri": "http://Tpia/20240321", "dts": { "inline": { "local": [ "tpia-20240321.htm" ] }, "schema": { "local": [ "tpia-20240321.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "tpia-20240321_def.xml" ] }, "labelLink": { "local": [ "tpia-20240321_lab.xml" ] }, "presentationLink": { "local": [ "tpia-20240321_pre.xml" ] } }, "keyStandard": 20, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 35, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 20 }, "report": { "R1": { "role": "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation", "longName": "000010 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "D240321", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "tpia-20240321.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "D240321", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "tpia-20240321.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Fiscal Year End", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Period End date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "SEC Form", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Registrant CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Number of common stock shares outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current with reporting", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r0" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r0" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r5" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r0" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r0" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Tax Identification Number (TIN)", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r0" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Voluntary filer", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r6" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Exchange", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_TextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TextBlockAbstract", "lang": { "en-us": { "role": { "label": "Details" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://Tpia/20240321/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r7" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001096906-24-000650-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001096906-24-000650-xbrl.zip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end XML 18 tpia-20240321_htm.xml IDEA: XBRL DOCUMENT 0001763329 2024-03-21 2024-03-21 0001763329 false 8-K 2024-03-21 MYCOTOPIA THERAPIES, INC. NV 000-56022 87-0645794 100 SE 2nd St Suite 2000 Miami FL 33131 954 233-3511 false false false false false